It is a reversibly inhibitor of acetylcholinesterase, indicated for the treatment of mild to moderate dementia of Alzheimer's type 1. The structural formula of Donepezil Hydrochloride is as follows:
A few methods have been reported for the determination of I including HPLC methods in tablets 2) and human plasma. [3] [4] [5] [6] [7] Isocratic HPLC method with fluorescence detection at 390 nm with an excitation at 325 nm for determination of donepezil in plasma and microdialysate samples was developed. 3) Analysis and enantioresolution of Donepezil was performed using capillary electrophoresis. 8) Determination of enantiomers of Donepezil Hydrochloride in rat plasma by liquid chromatography with fluorimetric detection of I with excitation at 318 nm and emission at 390 nm was described by Haginaka and Seyama. 9) Donepezil Hydrochloride was found to be stable in acid and alkaline medium, but liable to oxidative degradation using hydrogen peroxide.
2) Reviewing the literature in hand, it is obvious that no spectroscopic study has been attempted to determine donepezil hydrochloride in the presence of its oxidative degradate.
Upon scanning the absorption spectra of each I and II, it was observed that I has l max at 315 nm, at this wavelength II has a very little constant absorbance. Trials to use zero order absorption at 315 nm for determination of I in presence of II was successful for up to 70% of II. Zero order solve the problem of overlapping bands of I and II to certain extent but derivative spectrophotometry is a well established technique that is able to enhance the resolution of overlapping bands so to increase the selectivity of the method. D 1 and D 2 methods were constructed by measuring I at 332.1 nm and 340 nm (zero crossing of II), respectively. Different parameters affecting the D 1 and D 2 spectra were studied; namely Dl interval and smoothing factor. The best condition was by using 4 nm and 8 nm Dl interval for D 1 and D
2
, respectively, without smoothing.
The scientific novelty of the present work is that the methods used are simple, rapid, sensitive, and less expensive and less time consuming compared with other published LC methods. In addition, the aim of this work is to develop simple stability indicating methods for determination of I in presence of its oxidative degradate (II).
Experimental
Instrumentation A double beam UV-Visible spectrophotometer (SHI-MADZU, Japan) model UV-1601 PC with quartz cell of 1 cm path length, connected to IBM compatible computer and HP 680 inkjet printer. The bundled software was UVPC personal spectroscopy software version 3.7. The spectra bandwidth was 2 nm and wavelength-scanning speed 2800 nm/min. A spectrofluorimeter (SHIMADZU, Japan) model RF-1501 with an Epson Lx-300ϩPrinter. 1 cm quartz cell was used at low sensitivity and 2.5 nm bandwidth. TLC glass plates precoated with silica gel G F 254 (E. Merck). 25-ml Hamilton syringe. Chromatographic tank 20ϫ21ϫ9 cm (Desaga). SHI-MADZU Dual wavelength flying spot scanner, densitometer model CS9000. ). These methods were applied for the analysis of I in both powder and tablet form. Also, a spectrofluorimetric method depending on measuring the native fluorescence of I in deionized water using l l excitation 226 nm and l l emission 391 nm is suggested. The linearity range was found to be 0.32-3.20 m mg ml ؊1 using this method, I was determined in the presence of up to 90% of II. The proposed method was applied for the analysis of I in tablet form as well as in human plasma. The last method depends on using TLC separation of I from its oxidative degradate II and I was then determined spectrodensitometrically. The mobile phase was methanol : chloroform : 25% ammonia (16 : 64 : 0.1 by volume). The linearity range was found to be 2-15 m mg/spot. This method was applied to the analysis of I in both powder and tablet form using acetonitrile as a solvent. Donepezil Hydrochloride Working Solutions Eighty micrograms per milliliter in deionized water (for spectrophotometric method), 8 mg ml Ϫ1 in deionized water (for spectrofluorimetric method). They were prepared by suitably diluting the stock standard solution with deionized water.
Materials and Reagents

Donepezil Oxidative Degradate Standard Solution 200 m mg ml
؊1
It was prepared by adding 10 ml of 30% H 2 O 2 to 50 ml of standard stock solution of 200 mg ml Ϫ1 of I, refluxed for 4 h, evaporated to dryness and then the residue dissolved in 20 ml deionized water. The obtained solution was transferred into 50-ml volumetric flask and the volume was completed with suitable solvent to have a concentration of 200 mg ml Ϫ1 . Complete degradation was assured by the suggested TLC method, as indicated by the disappearance of I spot and appearance of one spot of II using methanol : chloroform : 25% ammonia. (16 : 64 : 0.1 by volume) as a mobile phase. Spotting of 5 mg at different successive times of reflux, showed complete degradation after 4 h.
Laboratory Prepared Mixtures
Solutions containing different ratios of I and II were prepared to contain 10-90% of II.
Procedure. Construction of Standard Curve for Spectrophotometric Methods Aliquots of I working standard solution equivalent to 80-560 mg were accurately transferred into a series of 10 ml volumetric flasks, the volume was completed to the mark with deionized water. The absorbance was measured at 315 nm. A calibration curve was constructed representing the absorbance versus concentration and the regression equation was computed. D 1 and D 2 curves were computed at Dl 4 nm, 8 nm and scaling factor 100, respectively. The peak amplitude values of D 1 and D 2 were measured at 332.1 nm and 340 nm, respectively (zero crossing of II).
Construction of Calibration Graph for Spectrofluorimetric Method Aliquots of I working standard solution equivalent to 8-80 mg were accurately transferred into a series of 25 ml volumetric flasks, the volume was completed to the mark with deionized water. The fluorescence was measured at l emission 391 nm using l excitation 226 nm. A calibration curve was constructed representing the fluorescence intensity versus concentration and the regression equation was computed.
Construction of Calibration Graph for Densitometric Method Aliquots of donepezil hydrochloride stock solution (1 mg ml
Ϫ1
) equivalent to 1-7.5 mg were accurately transferred into a series of 10 ml volumetric flasks; the volume was completed to the mark with acetonitrile. 20 ml of each of I, II and their laboratory prepared mixture solutions were applied to 10ϫ20 cm (TLC) glass plates precoated with 0.25 mm silica gel G F 254 using 25 ml Hamilton microsyringe. The plates were spotted 1.5 cm apart from each other and 1.5 cm apart from the bottom edge. The chromatographic chamber was pre-saturated with the developing solvent for one h. Application to Pharmaceutical Formulation Film coat of ten tablets were removed with the help of a filter paper moistened with ethanol, and then were weighed, crushed, finely powdered and mixed well. A weight equivalent to 20 mg of pure I was transferred into 100 ml volumetric flask; 20 ml acetonitrile were added and shaked vigorously. The volume was completed with acetonitrile and mixed well. The obtained solution was centrifuged for 5 min at 3000 rpm. Twenty milliliters of the centrifugate were transferred into 100-ml beaker and evaporated to dryness on hotplate. After cooled, it was dissolved in 20 ml deionized water accurately transferred to 100-ml volumetric flask and the volume was completed with deionized water to obtain concentration 80 mg ml Ϫ1 . Aliquots were transferred to 10-ml flasks and diluted with deionized water to obtain a concentration of 16 mg ml
. The general procedure under spectrophotometric methods was followed. For fluorimetry, the final solution obtained was diluted with deionized water to obtain a concentration of 0.64 mg ml Ϫ1 and the fluorescence intensity was measured. For densitometry, the previous procedure was followed for the extraction of I from Aricept tablets. The final solution obtained was diluted with acetonitrile to have a concentration of 0.4 mg ml Ϫ1 , 4 ml of this solution was diluted to 10 ml with acetonitrile. The general procedure under densitometric method was followed.
Application of Fluorimetric Method to Human Plasma
In a series of 10-ml measuring flasks, 1 ml blank (drug-free) plasma sample was spiked with different concentrations of Donepezil Hydrochloride, the volume was completed to the mark with acetonitrile to provide final concentrations from 2.4-24 mg ml Ϫ1 . The samples were centrifuged at 2300 rpm for 15 min. Two milliliters of the protein free supernatant were transferred to test tube then evaporated to dryness, cooled and 10 ml deionized water was added. The suggested method was applied as described under construction of calibration graph for spectrofluorimetric method. The concentration of I was calculated from regression equation.
Results and Discussion
The stability of I was studied according to the ICH guidelines for:
(a) Stress, Acid and Alkaline: 0.1 N HCl/0.1 N NaOH for 8 h, 1 N HCl/1 N NaOH for 12 h, 2 N HCl/2 N NaOH for 24 h finally 6 N HCl/6 N NaOH for 24 h.
( (c) Photodegradation: 2ϫ10 5 lux h and 6ϫ10 5 lux h. The degradation process under the previously mentioned conditions was followed using TLC and the compound was found to be stable under acidic, and alkaline condition but it is liable to degradation with hydrogen peroxide which is confirmed with a previous study on stability of donepezil Hydrochloride.
2) It is a single component which confirmed by TLC method as indicated by appearance of one spot of oxidative degradate after complete degradation and also confirmed by IR. The suggested degradate is:
Degradation product not interfered with donepezil hydrochloride quantification. No evidence of interactive degradation product.
2)
The present work is concerned with determination of Donepezil Hydrochloride in presence of its oxidative degradate.
In this work simple, sensitive and rapid methods are described for the determination of I in presence of its oxidative degradate (II). The first three are spectrophotometric methods are based on direct measurement of I at its l max 315 nm in presence of its oxidative degradate which does not show appreciable absorption at this wavelength as shown in Fig. 1 . A linear correlation was obtained between absorbance and concentration of the drug in a concentration range 8-56 mg ml Ϫ1 with mean percentage recovery of 100.02Ϯ0.77. The following regression equation was computed, Aϭ 0.0255Cϩ0.0067 where A is absorbance, C is concentration in mg ml Ϫ1 . The selectivity of the method was determined by analyzing mixtures of I and II at different ratios. The results showed that I can be determined in presence of up to 70% of II with mean recovery % of 100.70Ϯ1.24.
To increase the selectivity, D 1 and D 2 methods were constructed by measuring I at 332.1 nm and 340 nm (zero crossing of II), respectively, as shown in Fig. 2 .
A linear correlation was obtained between amplitude and concentration of the drug in a concentration range 8 A spectrofluorimetric method suggested is based on the fact that I has intense fluorescence while II has no fluorescence. The l emission and l excitation were found to be 391 and 226 nm, respectively.
l excitation was chosen to be 226 nm, as the results obtained using this l have the highest sensitivity and precision as demonstrated in the regression equation by the highest slope and lowest RSD.
The effect of different diluting solvents namely water, 0.1 M NaOH, 0.1 M HCl, 0.1 M acetic acid, 0.05 M H 2 SO 4 , methanol, ethanol, acetonitrile and buffers with different pH (2-8) on the fluorescence intensity of I is done. It was found that dilution with water gave the highest fluorescence intensity. Thus water was used as the chosen solvent.
A linear correlation was obtained between fluorescence intensity and concentration of the drug in a concentration range 0.32-3.20 mg ml Ϫ1 with mean percentage recovery of 99.47Ϯ1.49. The following regression equation was calculated I f ϭ41.739Cϩ1.7826 where I f is fluorescence intensity at 391 nm, C is concentration in mg ml
Ϫ1
. To assess the validity of proposed fluorimetric method as stability indicating method, it was applied on laboratory prepared mixtures of intact drug and its oxidative degradate in different ratios. The results showed that, the drug could be determined in presence of up to 90% of its oxidative degradate with mean recovery % of 99.79Ϯ1.35.
The last method is a TLC-densitometric one depends on measurement of I after chromatographic separation from II at 315 nm as it is l max of I. The Rf values obtained were 0.78 for I and 0.5 for II upon using methanol : chloroform : 25% ammonia (16 : 64 : 0.1 by volume) as a mobile phase. Carrying out several trials showed that the best separation was achieved upon using the above mentioned mobile phase. A linear correlation was obtained between peak area and concentration of the drug in a linear range 2-15 mg/spot with mean percentage recovery of 99.79Ϯ0.92. The following regression equation was calculated and found to be: Aϭ11850Cϩ57010 where A is peak area, C is concentration in mg/spot.
The selectivity of the densitometric method upon analyzing mixture of I and II was determined and the results showed that I could be determined in presence of II up to 80% with mean recovery % of 98.93Ϯ1.37.
The proposed methods were successfully applied to the determination of donepezil hydrochloride in its pharmaceutical dosage form, and validated by standard addition technique which found to be 98.51Ϯ0.46, 98.14Ϯ0.45 and 99.67Ϯ0.46 for D 0 , D 1 and D 2 methods, respectively. Application of standard addition technique to the analysis of donepezil hydrochloride in tablets and recovery % were calculated from the corresponding regression equations and were found to be 97.79Ϯ1.50 and 97.87Ϯ1.01 for fluorimetric and densitometric methods, respectively. The excellent recoveries of the standard addition technique indicate good accuracy of the proposed methods and there is no interference from the excipients.
The high sensitivity attained by the proposed fluorimetric method allowed the determination of the drug in plasma. A linear range was found to be 0.48-4.8 mg ml Ϫ1 with mean percentage recovery of 100.03Ϯ2.69 as shown in Table 1 .
Method validation was performed according to USP 10) for all the proposed methods. Table 2 shows the results of accuracy, repeatability and reproducibility of the methods.
Also, the methods were compared by a reference method, 11) no significant difference was found for accuracy and precision upon statistical analysis.
Conclusion
Donepezil Hydrochloride could be determined by simple, sensitive and accurate stability indicating methods, economic and more selective which suggested their suitability for the routine analysis and quality control of pharmaceutical formulation.The proposed fluorimetric method shows the highest sensitivity of all the proposed methods which allows its use to determine the drug in human plasma at low concentrations. 
2-15 mg/spot
a) The intraday (nϭ3), average of three different concentrations repeated three times within day. b) The interday (nϭ3), average of one concentration repeated three times in three successive days.
